Takeda Pharmaceuticals U.S.A., Inc. has entered a multi-year research partnership with two leading academic centers with a commitment to inflammatory bowel disease (IBD) research and care. The partnership, with the University of Chicago and the Icahn School of Medicine at Mount Sinai in New York, aims to advance novel therapies and treatment paradigms through information sharing, addressing research and data gaps, and collaborating on clinical and health outcome studies, as well as sharing of re...